Hansoh Pharmaceutical Group Company Limited

HK$34.80As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3692Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR 8.34%
Div yield 1.24%
ROE 19.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.54
PE TTM 27.21
TSR TTM (0.94%)
Mkt cap HK$211.0B
ROIC 108.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$35
(0.79%)
(93.66%)
Hold 0|3|9|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.50
0.54
0.60
0.64
19.09%
16.83%
32.30%
38.16%
Revenue¥B
10.14
10.11
9.859
10.32
11.11%
5.66%
2.02%
7.35%
Peers (US$26.91B)
Cap (US$)
PE
3.738B
6.110x
29.17B
81.44x
Capital
TTM
5Y
10Y
Leveragex
0.909
0.042
0.043
EBIT/Intx
0.932
0.249
0.226
Own earn%
30.13
32.87
40.51
Sh yield%
32.18
42.80
42.22
Owners
Insiders/Inst%
14.26
32.93
Short interest%
5.73
SBC / revenue%
2.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
26